|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00809 GLOBAL BIO-CHEM
Nominal 
0.081 -0.002 (-2.410%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 2,001,095 | 45.647% | 1,373,938 | 372,278 | 746,551 | 848,867 |
| Cost of Sales | (1,810,123) | 36.069% | (1,330,301) | (337,681) | (698,200) | (774,767) |
| Gross Profit | 190,972 | 337.638% | 43,637 | 34,597 | 48,351 | 74,100 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | 1,962,112 | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | 5,008,064 | -- | -- | (728,190) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (2,004) | (2,332) | |
| Profit / (Loss) before Taxation | 745,619 | -79.854% | 3,701,045 | (1,573,784) | (409,469) | (2,410,926) | |
| Taxation | 23,979 | -43.018% | 42,082 | 54,219 | (25,920) | (22,340) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 481,466 | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 76,497 | 34,588 | 3,317 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 769,598 | -81.783% | 4,224,593 | (1,443,068) | (400,801) | (2,429,949) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 323,400 | -56.900% | 750,348 | 726,173 | 790,314 | 724,423 |
| Depreciation & Amortisation | 228,506 | -6.182% | 243,563 | 330,509 | 402,513 | 456,928 |
| Directors' Emoluments | 1,396 | 12.039% | 1,246 | 1,429 | 1,685 | 1,597 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified (Modified Report) | Disclaimer | Disclaimer | Disclaimer |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 8.600 | -81.857% | 47.400 | -16.200 | -4.500 | -28.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.009 | -- | (0.006) | (0.010) | (0.053) | (0.003) |
| NBV per share ($) | (0.415) | -- | (0.453) | (0.846) | (0.732) | (0.658) |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -154,734 |
| %Change | -1.908% |
| EPS / (LPS) | HKD -0.017 |
| NBV Per Share ($) | HKD -0.444 |